Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
13 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Krazati“
Suchtreffer
Begriffe & Kennungen
Krazati · 4.8 · Lymphocyte count decreased Lymphocyte count decreased (which represents the incidence of laboratory findings,
Eintrag öffnenKrazati · 4.8 · QT interval prolongation resulted in dose interruption and/or reduction in 3.4% of patients (see sections 4.2
Eintrag öffnenKrazati · 4.8 · QT prolongation Any grade increase in QTcF interval from baseline occurred in 43.9% of patients. Increase in Q
Eintrag öffnenKrazati · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenKrazati · 4.8 · Special populations
Eintrag öffnenKrazati · 4.8 · Summary of the safety profile
Eintrag öffnenKrazati · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenKrazati · 4.8 · The adverse reaction frequencies from clinical studies are displayed as all-cause adverse event frequencies; a
Eintrag öffnenKrazati · 4.8 · The most common adverse reactions are diarrhoea (65.2%), nausea (59.9%), fatigue (54.3%), vomiting (50.3%), de
Eintrag öffnenKrazati · 4.8 · The most common adverse reactions leading to dose reduction or interruption are nausea (14.7%), diarrhoea (13.
Eintrag öffnenKrazati · 4.8 · The most common serious adverse reactions are vomiting (2.8%), nausea (2.1%), acute kidney injury (2.2%), diar
Eintrag öffnenKrazati · 4.8 · The most common severe adverse reactions (NCI CTCAE Grade ≥ 3) are fatigue (9.0%), anaemia (7.2%), ALT increas
Eintrag öffnenKrazati · 4.8 · glutamyltransferase increased, hepatic enzyme increased, liver function test increased, bilirubin conjugated i
Eintrag öffnen